+Vote!
The Earth Times Online Newspaper (Free subscription) | 28/08/2008
SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced that the Company will webcast its presentations at two upcoming investment conferences in September 2008. Illumina will webcast its presentation at the Thomas Weisel Health Care Conference in Boston, Massachusett
+Vote!
San Diego Union (Free subscription) | 13/08/2008
Illumina, a San Diego-based company that develops genetic analysis systems, said the underwriter of the company's public offering fully exercised its option to buy up to 525,000 additional shares. More than 4 million shares were sold to the public at an offering price of $87.50 a share, raising net proceeds of about $342.6 million, after deducting underwriting discounts and commissions and estimated...
+Vote!
24/7 Wall St. (Free subscription) | 07/08/2008
Illumina Inc. (NASDAQ: ILMN) has priced its proposed secondary offering of 3.5 million shares at $87.50 per share. This will result in net proceeds of roughly... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
+Vote!
Business Wire (Free subscription) | 07/08/2008
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the pricing of its public offering of 3,500,000 shares of common stock at a public offering price of $87.50 per
+Vote!
Extra Technology News (Free subscription) | 06/08/2008
Synamatix has become a member of the Illumina Connect program. The focus of the collaboration is to leverage SynaWorks, an integrated suite of bioinformatics solutions for next generation sequencers, recently launched by Synamatix. Illumina and Synamatix have signed an agreement to work closely together to provide users of the Illumina Genome Analyzer with enhanced solutions for the analysis and mining...
+Vote!
Fool.com (Free subscription) | 06/08/2008
With the stock hitting 52-week highs, what did investors expect to happen?
+Vote!
Forbes (Free subscription) | 05/08/2008
Company plans to tap equity market for more than $300M but says it doesn't have any big spending plans.
+Vote!
Business Wire (Free subscription) | 04/08/2008
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has filed a preliminary prospectus supplement to a shelf registration statement with the Securities and
+Vote!
Business Wire (Free subscription) | 04/08/2008
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Dr. Mostafa Ronaghi as Senior Vice President and Chief Technology Officer. As reported during
+Vote!
Business Wire (Free subscription) | 31/07/2008
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) announced today that the Company will webcast its presentation at the Leerink Swann Life Science Tools Roundtable Conference on
+Vote!
Business Wire (Free subscription) | 30/07/2008
CHICAGO--(BUSINESS WIRE)--Kevin Matras explains how to minimize your portfolio’s market risk and volatility by using the ‘beta
+Vote!
Business Wire (Free subscription) | 28/07/2008
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that GeneSeek Inc., a leading provider of genotyping services for agribusiness, is the first organization focusing on
+Vote!
San Diego Union (Free subscription) | 24/07/2008
Shares of genetics analysis company Illumina reached a record trading high of $92.50 yesterday after the company on Tuesday reported that second-quarter revenue and profit topped analysts' projections.
+Vote!
Fool.com (Free subscription) | 24/07/2008
Who's going to complain about double-digit growth?
+Vote!
The Street (Free subscription) | 23/07/2008
Today's strong action should lead to more upside in this leading biotech stock.